Stock profile

VISTAGEN THERAPEUTICS INC (VTGN)

VTGN · Latest close — as of Oct 13, 2026 · 13F data as of Jun 30, 2026 (2026 Q2)
Latest close
Data unavailable
No price in range
Tracked funds holding
0 of 149
2026 Q2 13F filings
Opened / added
0 / 0
vs previous quarter
Trimmed / exited
1
vs previous quarter

Super-investor holdings · 2026 Q2

No tracked fund reported a position in this stock in the latest 13F quarter.

Exited this quarter: OrbiMed Advisors.

Short interest

Shares short · Sep 15, 20262,707,020
Days to cover7.64

Shares short at recent settlements — Jun 30, 2026: 1.6M · Jul 15, 2026: 1.6M · Jul 31, 2026: 2.0M · Aug 14, 2026: 2.0M · Aug 31, 2026: 2.1M · Sep 15, 2026: 2.7M.

Source: FINRA Equity Short Interest (biweekly settlement data).

Insider trading · Form 4

Data unavailable — no Form 4 transactions for this ticker were parsed in the 90 days to Oct 14, 2026.

Politician trading · U.S. Congress

Data unavailable — no congressional STOCK Act transactions for this ticker were parsed in the current window (as of Oct 3, 2026).

Screens & lenses

This stock does not currently pass any tracked screen.

Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.